Vista sees 'a mixed bag' of cinema reopenings globally
And continuing delays in the release of blockbuster movies aren't helping.
And continuing delays in the release of blockbuster movies aren't helping.
The retailer has detailed strong sales recovery over the past six weeks.
A mid-year tally of progress in the annual Brokers Picks game reveals surprising turns.
New Zealand shares fell on the back of a grim update from Auckland International Airport.
F&P Healthcare has hired some 600 additional direct manufacturing staff locally.
AIA expects to take a $50-$90m ht from Covid-19 costs in its upcoming result.
One of the country's most costly divorces has ended in an agreement.
Investors continued to react to F&P Healthcare's record result yesterday.
Move marks the start of arrivals into New Zealand's tallest new office tower.
F&P Healthcare has delivered another record profit, but is its growth sustainable?
Advisers KPMG continue to review options for the fast food chain.
New Zealand shares rose, led higher by Fisher & Paykel Healthcare.
The Covid-19 pandemic is increasing demand for global telecommunications.
Why residential tenancy interests NZ's biggest listed property company.
Domestic capacity has built more quickly than expected and that's better job news
Capital raise should see the company through, Moa says.
As Rocket Lab gets back to high frequency launches to Earth's orbit Moon mission beckons
International crew on Auckland-LA route unjust target of Covid-19 fears.
Investors will find out on Monday if F&P Healthcare's high share price is justified.
What's going on with this listed real estate business?
New Zealand shares joined a global sell-off.
Green Cross committed to maintaining strong balance sheet to absorb impact of Covid-19.
Move likely to be the best decision for the firm and the country, Z Energy says.
The jobs going are across Qantas and Jetstar and represent about 20% of the workforce.
The pandemic saw Skellerup's costs rise and demand dwindle for some of its products.
Wirecard NZ accounts reveal subsequent events.
New Zealand shares rose, led by companies offering reliable dividends.
Wellington-based medtech uses sheep guts for human tissue regeneration.
A cornerstone investor of Ebos Group sold down a 9 per cent stake in the company.